Breaking down the barriers: challenges with development and implementation of an industry-sponsored antimicrobial stewardship data collection and analysis tool.

Autor:	Hermsen ED; Global Medical Affairs, Cubist Pharmaceuticals, Lexington, Massachusetts Department of Pharmacy Practice, College of Pharmacy, University of Nebraska Medical Center, Omaha., McDaneld PM; Global Medical Affairs, Cubist Pharmaceuticals, Lexington, Massachusetts Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, Worcester/Manchester., Eiland EH 3rd; Department of Pharmacy, Huntsville Hospital, Alabama., Destache CJ; Creighton University School of Pharmacy and Health Professions, Omaha, Nebraska., Lusardi K; Department of Pharmacy, University of Arkansas for Medical Sciences Medical Center, Little Rock., Estrada SJ; Department of Pharmacy, Lee Memorial Health System, Fort Myers, Florida., Mercier RC; College of Pharmacy, University of New Mexico, Albuquerque., DePestel DD; Global Medical Affairs, Cubist Pharmaceuticals, Lexington, Massachusetts., Lamp KC; Global Medical Affairs, Cubist Pharmaceuticals, Lexington, Massachusetts., Anderson E; Global Medical Affairs, Cubist Pharmaceuticals, Lexington, Massachusetts., Chung TJ; Global Medical Affairs, Cubist Pharmaceuticals, Lexington, Massachusetts., McKinnon PS; Global Medical Affairs, Cubist Pharmaceuticals, Lexington, Massachusetts.
Jazyk:	angličtina
Zdroj:	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2014 Oct 15; Vol. 59 Suppl 3, pp. S179-84.
DOI:	10.1093/cid/ciu539
Abstrakt:	Partnership between clinicians and the pharmaceutical industry with a focus on antimicrobial stewardship research initiatives is a necessary step toward meeting the shared goals of combating inappropriate antimicrobial use, improving patient outcomes, and minimizing resistance development. Achieving these goals requires outcomes-focused data collection and monitoring tools for antimicrobial stewardship programs (ASP) that consider real-world data about how antimicrobials are used to treat patients. Here we highlight the experiences and challenges associated with the development and implementation of an industry-sponsored electronic antimicrobial stewardship data collection and analysis tool (AS-DCAT). The benefits and risks of the industry-sponsored AS-DCAT from the perspectives of the sponsoring company and participating sites are discussed. Barriers encountered as well as general considerations and recommendations for preventing or overcoming those barriers for future studies and tool development are provided. (© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu